Table 5.

TTC staining of the brain for the Gsk-3β validation experiment.

Groups	Cerebral Infarct Volume (%)
Sham	0.00 ± 0.00
MCAO	28.78 ± 3.92 ***
DHI	21.79 ± 4.54 ***,∆∆
MCAO + DMSO	28.75 ± 3.28 ***,□□□
MCAO + inhibitor	22.62 ± 4.26 ***,∆∆
MCAO + inhibitor + DHI	19.42 ± 3.48 ***,△△△

(*** P < 0.001 vs. the sham group; ^∆∆ P < 0.01, ^△△△ P < 0.001 vs. the MCAO group or MCAO + DMSO group; ^□□□ P < 0.001 versus the DHI group).